All these findings elucidated that PTTG, FGF-2, and VEGF might act in synergy from the early development to increase the invasiveness and angiogenesis of pituitary adenomas, especially prolactinoma (58) and growth hormone–secreting adenomas (59). This evidence concerns the gene FGF2 and pituitary gland adenoma.